Advertisement

Cervical Cancer

How tamoxifen (sometimes) induces uterine cancer: affecting the PI3K pathway

Dec 15, 2021

Long-term use of tamoxifen is associated with an increased risk for the development of uterine cancer. New research shows that tamoxifen directly activates a signaling pathway (PIK3) that is a well-kn...

Updated results from RxPONDER confirm importance of menopausal status on treatment efficacy

Dec 14, 2021

The phase 3 RxPONDER trial evaluated the benefit of adjuvant chemotherapy followed by endocrine therapy in women with HR-positive, HER2-negative, early-stage breast cancer and 1–3 positive nodes. Up...

CME/CE: Exploring Healthcare Super-Utilization in Gynecologic Oncology

Sep 13, 2021

Upon completion of the educational activity, participants should be able to: Discuss a study that examined the prevalence of healthcare super-utilization among gynecologic oncology patients....

Black Women Underrepresented in Immunotherapy Trials

Jul 23, 2021

“Racial inequity in healthcare delivery and outcomes in the United States is well-documented, and outcomes for breast and gynecologic cancers are no exception,” explains Katherine V. Grette, MD. ...

Exploring Healthcare Super-Utilization in Gynecologic Oncology

Jun 18, 2021

Unplanned acute care continues to be a major contributor to growing healthcare costs in the United States, especially among patients with cancer. Quality measures have been developed to reduce healthc...

CME/CE: Examining the Risk of VTE in Ovarian Cancer

May 03, 2021

This course discusses a meta-analysis of the most reported and discussed risk factors for venous thromboembolism in patients with ovarian cancer that was conducted to summarize and quantify the result...

Updated Guidance on Fertility Preservation & Post-Treatment Pregnancy in Patients With Post-Pubertal Cancer

Feb 22, 2021

With long-term survivorship increasingly achievable among patients with cancer, many in this population face the outcomes of treatment-related late effects, explain Richard Anderson, MD, PhD, Matteo L...

Examining the Risk of VTE in Ovarian Cancer

Dec 15, 2020

Published research has shown that women with ovarian cancer have among the highest rates of venous thromboembolisms (VTEs) of all patients with cancer. “An estimated 5% to 25% of patients with ovari...

Prescribed Medical Cannabis in Women With Gynecologic Malignancies

Dec 14, 2020

Although cannabis remains illegal in many parts of the United States, 33 states have approved medical cannabis programs as of March 2020. “With the likely expansion of medical cannabis across the US...

Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer

Oct 13, 2020

Previous research has shown that women with early-stage cervical cancer who undergo radical hysterectomy are usually cured, with some reports demonstrating 5-year disease-free survival rates that exce...

Minimally Invasive vs. Open Radical Hysterectomy for Cervical Cancer

Aug 18, 2020

Minimally invasive techniques for cancer surgery are becoming increasingly common, but recent evidence questions the safety of minimally invasive radical hysterectomy for cervical cancer. The objectiv...

Characterizing the Treatment of Women With Early Stage Leiomyosarcoma

Aug 15, 2020

Leiomyosarcoma (LMS) is a rare gynecologic malignancy, but it contributes to a significant proportion of uterine cancer deaths. Most LMS cases are uterine-confined, early-stage disease, and while surg...

CME: Risk of Oral HPV Among Female Adolescents

Jul 01, 2020

This course discusses a study that assessed the risk factors for oral HPV, as well as the association of HPV vaccination with HPV prevalence in the oral cavity, in sexually active female adolescents r...

Cervical Intraepithelial Neoplasia & Cancer Risk

Jun 26, 2020

Prior research indicates that women who are treated for cervical intraepithelial neoplasia (CIN) remain at increased risk of developing cervical cancer when compared with women with normal cytology re...

Trends in Brachytherapy for Cervical Cancer

Jun 16, 2020

Evidence shows brachytherapy to be an essential component of definitive treatment for locally advanced cervical cancer (LACC) in combination with external beam radiation and cisplatin-based chemothera...

ASCO: Virtual Meeting Kicks Off May 29

May 20, 2020

Three days packed with presentations The American Society of Clinical Oncology is the leading oncology research meeting worldwide, but just like other medical conferences, ASCO 2020 was forced to mak...

Article Addresses Management of Cancer Care During COVID-19

Mar 29, 2020

MONDAY, March 23, 2020 (HealthDay News) -- Management of cancer care during the coronavirus 2019 (COVID-19) pandemic is addressed in a special feature article published online March 20 in the Journal ...

CME: A Call to Action to Increase HPV Awareness & Vaccination Rates

Mar 20, 2020

This course discusses the findings of questions on human papillomavirus knowledge from a cross-sectional analysis of the Health Information National Trend Survey....

Brachytherapy Improves Survival in Women With Cervical Cancer

Jan 30, 2020

Although cervical cancer rates in the United States have dropped significantly due to improved detection of pre-cancerous lesions and the advent of the human papillomavirus vaccine, it is still the fo...